Our Litigators have defended against mass tort claims, our Corporate Finance attorneys have worked on private placements and public offerings to raise capital for pharmaceutical concerns, and our Business attorneys have crafted licensing arrangements to outsource manufacturing and provide more efficient utilization of capital resources.
In terms of environmental issues, our Environmental team has supervised water remediation programs and advised concerning current good manufacturing practice issues. Our Intellectual Property attorneys are qualified to protect research and development through obtaining patents, trademarks, and protection of technology through confidentiality measures. Our Government and Regulatory Affairs professionals work to establish laws that protect the intellectual property and work products of pharmaceutical companies.
Whether our clients’ needs involve development agreements, production or outsourcing arrangements, protection of intellectual property, NDAs, or other regulatory issues, our attorneys have the capability and resources to effectively accommodate pharmaceutical enterprise.
